PortfoliosLab logo

BridgeBio Pharma, Inc. (BBIO)

Equity · Currency in USD · Last updated Dec 8, 2022

Company Info

ISINUS10806X1028
CUSIP10806X102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$9.25
Year Range$5.21 - $42.65
EMA (50)$9.76
EMA (200)$12.76
Average Volume$1.32M
Market Capitalization$1.40B

BBIOShare Price Chart


Loading data...

BBIOPerformance

The chart shows the growth of $10,000 invested in BridgeBio Pharma, Inc. in Jun 2019 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,358 for a total return of roughly -66.42%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
23.50%
-2.09%
BBIO (BridgeBio Pharma, Inc.)
Benchmark (^GSPC)

BBIOCompare to other instruments

Search for stocks, ETFs, and funds to compare with BBIO

BBIOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-6.00%4.33%
6M14.91%-5.45%
YTD-44.54%-17.46%
1Y-76.49%-14.32%
5Y-27.13%8.97%
10Y-27.13%8.97%

BBIOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-40.83%-20.97%30.13%-20.99%-14.84%32.94%-4.63%21.25%-5.33%4.93%-10.16%-1.28%
2021-20.18%24.52%-12.85%-9.22%5.87%2.97%-12.32%-6.25%-6.47%5.36%-17.98%-58.81%
2020-1.60%-7.57%-9.03%5.28%-3.93%11.18%-13.71%6.11%25.65%2.29%30.90%41.54%
2019-2.11%8.82%3.85%-29.56%5.31%28.26%20.86%

BBIOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BridgeBio Pharma, Inc. Sharpe ratio is -0.61. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.20JulyAugustSeptemberOctoberNovemberDecember
-0.61
-0.67
BBIO (BridgeBio Pharma, Inc.)
Benchmark (^GSPC)

BBIODividend History


BridgeBio Pharma, Inc. doesn't pay dividends

BBIODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-87.21%
-17.98%
BBIO (BridgeBio Pharma, Inc.)
Benchmark (^GSPC)

BBIOWorst Drawdowns

The table below shows the maximum drawdowns of the BridgeBio Pharma, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BridgeBio Pharma, Inc. is 92.80%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.8%Feb 9, 2021317May 11, 2022
-65.45%Dec 24, 201958Mar 18, 2020175Nov 24, 2020233
-44.53%Sep 4, 201931Oct 16, 201925Nov 20, 201956
-21.99%Jan 4, 202117Jan 27, 20218Feb 8, 202125
-16.79%Nov 25, 20192Nov 26, 20198Dec 9, 201910
-14.67%Jul 23, 201917Aug 14, 20198Aug 26, 201925
-12.87%Jul 12, 20193Jul 16, 20194Jul 22, 20197
-6.7%Dec 13, 20193Dec 17, 20191Dec 18, 20194
-5.62%Jul 8, 20192Jul 9, 20192Jul 11, 20194
-5.28%Aug 28, 20191Aug 28, 20193Sep 3, 20194

BBIOVolatility Chart

Current BridgeBio Pharma, Inc. volatility is 72.38%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%JulyAugustSeptemberOctoberNovemberDecember
72.38%
22.83%
BBIO (BridgeBio Pharma, Inc.)
Benchmark (^GSPC)